{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreib5bhlaiublo43qrjdqg64g4yynkhbhav4amcscjr74le3gghyaem",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3meyggwu4nql2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiehui3qkmhejjuiia74fb6hbskwyoy37y4xkzsjq3pgbihqle25ae"
    },
    "mimeType": "image/jpeg",
    "size": 329854
  },
  "path": "/news/2026-02-ibd-tracks-patients-links-dysplasia.html",
  "publishedAt": "2026-02-16T10:31:24.000Z",
  "site": "https://medicalxpress.com",
  "tags": [
    "Oncology & Cancer"
  ],
  "textContent": "Precancerous colorectal lesions, or dysplasia, in patients with inflammatory bowel disease (IBD) confer markedly different risks of future colorectal cancer depending on dysplasia grade, according to a comprehensive registry study from Karolinska Institutet, Sweden, and NYU Grossman School of Medicine, New York, published in Clinical Gastroenterology and Hepatology.",
  "title": "IBD study tracks 54,000 patients, links dysplasia grade to cancer risk"
}